Stock Research for APDN


Featured Broker: Ally Invest

Get the due diligence for another stock.


APDN Stock Chart & Research Data

The APDN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APDN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


APDN Due diligence Resources & Stock Charts

The APDN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View APDN Detailed Price Forecast - CNN Money CNN View APDN Detailed Summary - Google Finance
Yahoo View APDN Detailed Summary - Yahoo! Finance Zacks View APDN Stock Research & Analysis -

Stock Analysis

TradeIdeas View APDN Trends & Analysis - Trade-Ideas Barrons View APDN Major Holders - Barrons
NASDAQ View APDN Call Transcripts - NASDAQ Seeking View APDN Breaking News & Analysis - Seeking Alpha
Spotlight View APDN Annual Report - OTC Report View APDN OTC Short Report -
TradeKing View APDN Fundamentals - TradeKing Charts View APDN SEC Filings - Bar Chart
WSJ View Historical Prices for APDN - The WSJ Morningstar View Performance/Total Return for APDN - Morningstar
MarketWatch View the Analyst Estimates for APDN - MarketWatch CNBC View the Earnings History for APDN - CNBC
StockMarketWatch View the APDN Earnings - StockMarketWatch MacroAxis View APDN Buy or Sell Recommendations - MacroAxis
Bullish View the APDN Bullish Patterns - American Bulls Short Pains View APDN Short Pain Metrics -

Social Media Mentions

StockTwits View APDN Stock Mentions - StockTwits PennyStocks View APDN Stock Mentions - PennyStockTweets
Twitter View APDN Stock Mentions - Twitter Invest Hub View APDN Investment Forum News - Investor Hub
Yahoo View APDN Stock Mentions - Yahoo! Message Board Seeking Alpha View APDN Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for APDN - Insider Cow View Insider Transactions for APDN - Insider Cow
CNBC View APDN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for APDN - OTC Markets
Yahoo View Insider Transactions for APDN - Yahoo! Finance NASDAQ View Institutional Holdings for APDN - NASDAQ

Stock Charts

FinViz View APDN Stock Insight & Charts - StockCharts View APDN Investment Charts -
BarChart View APDN Stock Overview & Charts - BarChart Trading View View APDN User Generated Charts - Trading View

Latest Financial News for APDN

Applied DNA Expands Cannabis Tagging Portfolio to Address Large Growers
Posted on Tuesday September 25, 2018

Applied DNA Sciences Inc. (APDN) (“Applied DNA” or the “Company”) announced today that it is launching an additional system to tag the industry’s larger volume cannabis or hemp grows as part of TheraCann International’s ETCH Biotrace™ solution. The Company’s laboratory services and in-field testing systems round out the solution to support claims of traceability, quality and intellectual properties surrounding a cannabis brand. “The tremendous interest that came following the show has really accelerated our expansion of tagging solutions to meet the varied cannabis market conditions, including size of grower, indoor, outdoor or hybrid grow, or even the size of plant(s) that justifies the expansion of our tagging equipment solutions,” said Gordon Hope, Director of Cannabis Business Development at Applied DNA Sciences.

Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
Posted on Thursday September 20, 2018

Applied DNA Sciences Inc. (APDN) (“Applied DNA” or the “Company”) announced today that LineaRx, Inc. (“LineaRx”), its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement (the “Agreement”) with Takis S.R.L. and Evvivax S.R.L. (“Takis/Evvivax”), biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively. Under the terms of the Agreement, LineaRx and Takis/Evvivax will jointly develop linear DNA expression vectors for two of Takis/Evvivax’s anti-cancer vaccine candidates utilizing LineaRx’s linear DNA technology.

Applied DNA Forms Wholly Owned Subsidiary, LineaRx, to Develop Large-Scale, PCR-Produced DNA for Biotherapeutics
Posted on Tuesday September 18, 2018

Applied DNA Sciences Inc., (NASDAQ: APDN, “Applied DNA” or the “Company”), the leader in large-scale PCR-based DNA manufacturing, announced today the formation of LineaRx, Inc., a wholly owned subsidiary. Its purpose is to commercialize the Company’s extensive experience in the design, manufacture and chemical modification of DNA by large scale polymerase chain reaction (“PCR”) in the field of biotherapeutics, specifically gene and cellular therapies as well as vaccines. The Company believes that the opportunity and markets for these biotherapeutics are substantial, and that its proprietary PCR technology offers the potential for improved outcomes relative to current plasmid and viral vector production technologies.

Applied DNA Executes New Two-Year Contract with the U.S. Defense Logistics Agency
Posted on Tuesday September 11, 2018

Applied DNA Sciences Inc., (NASDAQ:APDN, “Applied DNA,”), the leader in large-scale PCR-based DNA manufacturing, announced today the signing of a new contract to continue uninterrupted service of the Company’s DNA marking program at the Defense Logistics Agency’s (DLA) Land and Maritime’s Product Test Center (PTC) in Columbus, Ohio. The contract outlines the Company’s provision of supplies and services, including creation of unique DNA marks in various inks, QC authentication testing and training. “We appreciate the DLA’s continuing support of our taggant technology platform in extending this contract for the marking of system-critical microcircuits,” stated Janice Meraglia, Vice President of Government and Military Programs at Applied DNA.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.